Sumatriptan and Naproxen Sodium
These highlights do not include all the information needed to use SUMATRIPTAN AND NAPROXEN SODIUM TABLETS safely and effectively. See full prescribing information for SUMATRIPTAN AND NAPROXEN SODIUM TABLETS. SUMATRIPTAN and NAPROXEN SODIUM tablets, for oral use Initial U.S. Approval: 2008
6c0c9268-315d-4c0a-943f-58b21b738d11
HUMAN PRESCRIPTION DRUG LABEL
Dec 10, 2020
Innovida Phamaceutique Corporation
DUNS: 080892908
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sumatriptan and Naproxen Sodium
Product Details
FDA regulatory identification and product classification information